Detailed Information

Cited 5 time in webofscience Cited 5 time in scopus
Metadata Downloads

ANALYSIS OF POSTOPERATIVE ULTRASONOGRAPHY SURVEILLANCE AFTER HEMITHYROIDECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A MULTICENTER STUDY

Full metadata record
DC Field Value Language
dc.contributor.authorBaek, Hye Jin-
dc.contributor.authorKim, Dong Wook-
dc.contributor.authorLee, Chang Yoon-
dc.contributor.authorHuh, Jung Yin-
dc.contributor.authorSung, Jin Yong-
dc.contributor.authorChoi, Yoon Jung-
dc.date.accessioned2022-12-26T18:35:10Z-
dc.date.available2022-12-26T18:35:10Z-
dc.date.issued2017-07-
dc.identifier.issn1530-891X-
dc.identifier.issn1934-2403-
dc.identifier.urihttps://scholarworks.gnu.ac.kr/handle/sw.gnu/13614-
dc.description.abstractObjective: The optimal follow-up interval for postoperative ultrasonography (US) surveillance after hemithyroidectomy in patients with papillary thyroid microcarcinoma (PTMC) is unclear. The purpose of this study was to evaluate the prevalence of tumor recurrence/persistence and to investigate the appropriateness of postoperative US surveillance in PTMC patients who underwent hemithyroidectomy. Methods: Our institutional review board approved this retrospective study. From 2000 to 2011, 800 patients underwent hemithyroidectomy as treatment for PTMC, as well as at least one session of postoperative follow-up US, at four different institutions. The images and data of postoperative US surveillance were retrospectively investigated by experienced radiologists at each institution. Based on the follow-up US and histopathologic results, locoregional tumor recurrence/persistence was determined. Results: Of the 800 patients, 82.2% had T1a, 17.8% had T3, and none had T1b, T2, T4a, or T4b disease; 6.9% had unknown N stage, 80.1% had N0, 13% had N1a, and none had N1b, based on histopathology. There were also no cases of distant metastasis after hemithyroidectomy. Among the patients, 784 (98%) showed no tumor recurrence/ persistence, and 16 (2%) showed locoregional tumor recurrence/persistence during the follow-up period. The patients differed in the number of sessions and the intervals of postoperative follow-up US. In the 16 patients with tumor recurrence/persistence, the mean interval of postoperative follow-up US since the first US detection of tumor recurrence/persistence was 42.9 +/- 25.9 months. All recurrence/ persistence cases were subcentimeter. Conclusion: Postoperative US surveillance at 1or 2-year intervals may be unnecessary because of the very low recurrence rate in PTMC.-
dc.format.extent9-
dc.language영어-
dc.language.isoENG-
dc.publisherAMER ASSOC CLINICAL ENDOCRINOLOGISTS-
dc.titleANALYSIS OF POSTOPERATIVE ULTRASONOGRAPHY SURVEILLANCE AFTER HEMITHYROIDECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A MULTICENTER STUDY-
dc.typeArticle-
dc.publisher.location미국-
dc.identifier.doi10.4158/EP161723.OR-
dc.identifier.scopusid2-s2.0-85029667921-
dc.identifier.wosid000411113000006-
dc.identifier.bibliographicCitationENDOCRINE PRACTICE, v.23, no.7, pp 794 - 802-
dc.citation.titleENDOCRINE PRACTICE-
dc.citation.volume23-
dc.citation.number7-
dc.citation.startPage794-
dc.citation.endPage802-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaEndocrinology & Metabolism-
dc.relation.journalWebOfScienceCategoryEndocrinology & Metabolism-
dc.subject.keywordPlusFOLLOW-UP-
dc.subject.keywordPlusCARCINOMA-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusULTRASOUND-
dc.subject.keywordPlusLOBECTOMY-
dc.subject.keywordPlusFEATURES-
dc.subject.keywordPlusNODULES-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusNODES-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE